Discover 2,716 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,716
Deep rTMS for Mild Neurocognitive Disorder in Older Adults
for
Mild Neurocognitive Disorder
Location: Hamilton
Sponsor: St. Joseph's Healthcare Hamilton
Sex: All
Age: 60 - 70+
Code: NCT07038798
Recruiting
The Effect of Dairy Intake on Body Weight and Composition and Metabolic Health in Adolescents and Seniors
Digital Bridge: Using Technology to Support Patient-centered Care Transitions From Hospital to Home
for
Older Adults With Complex Care Needs
Location: Toronto
Sponsor: Mount Sinai Hospital, Canada
Sex: All
Age: 60+
Code: NCT04287192
Recruiting
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
for
Chronic Obstructive Pulmonary Disease
Location: Boston MA, Baltimore MD, Miami FL, DuBois PA,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07053423
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Halifax, New Haven CT, Hackensack NJ, Toronto,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT06988488
Phase1, Phase2, Recruiting
Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators
for
X-Linked Myotubular Myopathy
Location: Boston MA, Toronto, Chicago IL, Dallas TX, Portland OR
Sponsor: Astellas Gene Therapies
Sex: Male
Age: 0 - 3
Code: NCT07052929
Phase1, Phase2, Recruiting
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
for
Metastatic Castration Sensitive Prostate Cancer (mCSPC),